Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2025-12-27 @ 11:23 PM
Study NCT ID:
NCT04847557
Status:
COMPLETED
Last Update Posted:
2025-08-20
First Post:
2021-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-26
First Submit QC Date:
None
Study First Post Date:
2021-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-02
Results First Submit QC Date:
None
Results First Post Date:
2025-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-15
Last Update Post Date:
2025-08-20
Last Update Post Date Type:
ACTUAL